HLB Pharmaceutical Co., Ltd (047920.KQ)

KRW 20500.0

(2.5%)

Long Term Debt Summary of HLB Pharmaceutical Co., Ltd

  • HLB Pharmaceutical Co., Ltd's latest annual long term debt in 2023 was 988.75 Million KRW , down -40.29% from previous year.
  • HLB Pharmaceutical Co., Ltd's latest quarterly long term debt in 2024 Q2 was 532.76 Million KRW , up 100.0% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported annual long term debt of 1.65 Billion KRW in 2022, down -22.59% from previous year.
  • HLB Pharmaceutical Co., Ltd reported annual long term debt of 2.13 Billion KRW in 2021, up 52.79% from previous year.
  • HLB Pharmaceutical Co., Ltd reported quarterly long term debt of 774.71 Million KRW for 2024 Q1, down 0.0% from previous quarter.
  • HLB Pharmaceutical Co., Ltd reported quarterly long term debt of 1.47 Billion KRW for 2023 Q2, down -42.86% from previous quarter.

Annual Long Term Debt Chart of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Historical Annual Long Term Debt of HLB Pharmaceutical Co., Ltd (2023 - 2016)

Year Long Term Debt Long Term Debt Growth
2023 988.75 Million KRW -40.29%
2022 1.65 Billion KRW -22.59%
2021 2.13 Billion KRW 52.79%
2020 1.4 Billion KRW -11.39%
2019 1.58 Billion KRW 25.4%
2018 1.26 Billion KRW -55.63%
2017 2.84 Billion KRW -78.43%
2016 13.16 Billion KRW 0.0%

Peer Long Term Debt Comparison of HLB Pharmaceutical Co., Ltd

Name Long Term Debt Long Term Debt Difference
CMG Pharmaceutical Co., Ltd. 19.06 Billion KRW 94.813%
Celltrion Pharm, Inc. 4.33 Billion KRW 77.182%
Huons Global Co., Ltd. 66.94 Billion KRW 98.523%
DongKook Pharmaceutical Co., Ltd. 18.74 Billion KRW 94.727%
Enzychem Lifesciences Corporation 1.02 Billion KRW 3.536%
Humedix Co., Ltd. 1.75 Billion KRW 43.671%
Boditech Med Inc. 2.09 Billion KRW 52.915%
EuBiologics Co., Ltd. 2.8 Billion KRW 64.687%
FutureChem Co.,Ltd 2.61 Billion KRW 62.258%
Huons Co., Ltd. 58.35 Billion KRW 98.305%
BNC Korea Co., Ltd. 301.69 Million KRW -227.739%
AptaBio Therapeutics Inc. 13.56 Billion KRW 92.713%